These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 9270035)
1. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis. Jakubczak JL; Chisari FV; Merlino G Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035 [TBL] [Abstract][Full Text] [Related]
2. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051 [TBL] [Abstract][Full Text] [Related]
3. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha. Vail ME; Pierce RH; Fausto N Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255 [TBL] [Abstract][Full Text] [Related]
4. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Santoni-Rugiu E; Jensen MR; Thorgeirsson SS Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068 [TBL] [Abstract][Full Text] [Related]
5. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice. Ghebranious N; Sell S Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635 [TBL] [Abstract][Full Text] [Related]
7. Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1. Ono M; Morisawa K; Nie J; Ota K; Taniguchi T; Saibara T; Onishi S Cancer Res; 1998 May; 58(9):1813-6. PubMed ID: 9581818 [TBL] [Abstract][Full Text] [Related]
8. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551 [TBL] [Abstract][Full Text] [Related]
10. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene. Laird AD; Brown PI; Fausto N Cancer Res; 1994 Aug; 54(15):4224-32. PubMed ID: 8033155 [TBL] [Abstract][Full Text] [Related]
15. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. Takagi H; Sharp R; Takayama H; Anver MR; Ward JM; Merlino G Cancer Res; 1993 Sep; 53(18):4329-36. PubMed ID: 8364928 [TBL] [Abstract][Full Text] [Related]
16. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Dunsford HA; Sell S; Chisari FV Cancer Res; 1990 Jun; 50(11):3400-7. PubMed ID: 1692259 [TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Masuhara M; Yasunaga M; Tanigawa K; Tamura F; Yamashita S; Sakaida I; Okita K Hepatology; 1996 Aug; 24(2):323-9. PubMed ID: 8690400 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer. Calvisi DF; Thorgeirsson SS Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070 [TBL] [Abstract][Full Text] [Related]
19. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice. Factor VM; Jensen MR; Thorgeirsson SS Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983 [TBL] [Abstract][Full Text] [Related]
20. Development of liver tumors in transforming growth factor alpha transgenic mice. Lee GH; Merlino G; Fausto N Cancer Res; 1992 Oct; 52(19):5162-70. PubMed ID: 1327502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]